Clinical Trial Update: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria [Phase 1, Phase 2]

View source ↗

Summary

This entry reports on a Phase 1/2 clinical trial evaluating crovalimab in healthy volunteers and patients with paroxysmal nocturnal hemoglobinuria, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Crovalimab (crovalimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Paroxysmal Hemoglobinuria, Nocturnal | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING